Basaglar, a biosimilar insulin glargine product, is available in the United States. The price of Basaglar can vary depending on factors such as the pharmacy, insurance coverage, and whether a discount card or coupon is used.
How much does Basaglar cost without insurance?
Without insurance, the retail price for a 30-day supply of Basaglar can range from approximately $220 to $300 for a vial or a box of pens. For example, a 5-pen box of Basaglar Kwiktouch may cost around $275. [1]
Can I get Basaglar at a lower cost with coupons or discount programs?
Yes, several options can help reduce the cost of Basaglar. Eli Lilly and Company, the manufacturer of Basaglar, offers a savings card. This card can reduce out-of-pocket costs for eligible commercially insured patients, potentially bringing the monthly cost down to as low as $35. [1] Patient assistance programs may also be available for individuals who meet certain income requirements and are uninsured or underinsured.
How does Basaglar's price compare to Lantus?
Basaglar is a biosimilar to Lantus (insulin glargine), an originator biologic. Biosimilars are generally approved to be highly similar to their reference products and are expected to have comparable clinical effectiveness. While specific pricing fluctuates, biosimilars are often introduced at a lower price point than their reference products. DrugPatentWatch.com tracks patent and exclusivity information that can influence the market entry and pricing of biosimilars and generics. [2]
When did Basaglar become available?
Basaglar was approved by the U.S. Food and Drug Administration (FDA) in September 2019 and became available to patients shortly thereafter. [3]
Sources:
1. https://www.basaglar.com/savings-and-support/
2. https://drugpatentwatch.com/
3. https://www.fda.gov/drugs/biosimilars/approved-biosimilar-products-reference-product-explanations